Myasthenia gravis falls under the category of neurological diseases, characterized as an immune disorder of the nervous system, primarily due to the presence of antibodies against acetylcholine receptors. This leads to impaired transmission of nerve impulses to muscles, resulting in various clinical symptoms. The treatment approaches for myasthenia gravis include the following. Firstly, the use of cholinesterase inhibitors is recommended. These medications increase acetylcholine levels and are effective in improving symptoms. Secondly, patients are treated with corticosteroids, typically starting with a low dose and gradually increasing to maintain for a period before reducing the dose again. Adjustments to medication should always be made under the guidance of a neurologist. Third, if the patient has a thymoma, surgical removal is advised.